• Je něco špatně v tomto záznamu ?

How to make usage of the standardized EuroFlow 8-color protocols possible for instruments of different manufacturers

M. Nováková, H. Glier, N. Brdičková, M. Vlková, AH. Santos, M. Lima, M. Roussel, J. Flores-Montero, T. Szczepanski, S. Böttcher, VHJ. van der Velden, P. Fernandez, E. Mejstříková, L. Burgos, B. Paiva, JJM. van Dongen, A. Orfao, T. Kalina,

. 2019 ; 475 (-) : 112388. [pub] 20171120

Jazyk angličtina Země Nizozemsko

Typ dokumentu časopisecké články, práce podpořená grantem

Perzistentní odkaz   https://www.medvik.cz/link/bmc20023414

A critical component of the EuroFlow standardization of leukemia/lymphoma immunophenotyping is instrument setup. Initially, the EuroFlow consortium developed a step-by-step standard operating protocol for instrument setup of ≥8-color flow cytometers that were available in 2006, when the EuroFlow activities started. Currently, there are 14 instruments from 9 manufacturers capable of 3-laser excitation and ≥8 color measurements. The specific adaptations required in the instrument set-up to enable them to acquire the standardized 8-color EuroFlow protocols are described here. Overall, all 14 instruments can be fitted with similar violet, blue and red lasers for simultaneous measurements of ≥8 fluorescent dyes. Since individual instruments differ both on their dynamic range (scale) and emission filters, it is not accurate to simply recalculate the target values to different scale, but adjustment of PMT voltages to a given emission filter and fluorochrome, is essential. For this purpose, EuroFlow has developed an approach using Type IIB (spectrally matching) particles to set-up standardized and fully comparable fluorescence measurements, in instruments from different manufacturers, as demonstrated here for the FACSCanto II, and Navios and MACSQuant flow cytometers. Data acquired after such adjustment on any of the tested cytometry platforms could be fully superimposed and therefore analyzed together. The proposed approach can be used to derive target values for any combination of spectrally distinct fluorochromes and any distinct emission filter of any new flow cytometry platform, which enables the measurement of the 8-color EuroFlow panels in a standardized way, by creating superimposable datafiles.

000      
00000naa a2200000 a 4500
001      
bmc20023414
003      
CZ-PrNML
005      
20201214125956.0
007      
ta
008      
201125s2019 ne f 000 0|eng||
009      
AR
024    7_
$a 10.1016/j.jim.2017.11.007 $2 doi
035    __
$a (PubMed)29154914
040    __
$a ABA008 $b cze $d ABA008 $e AACR2
041    0_
$a eng
044    __
$a ne
100    1_
$a Nováková, Michaela $u CLIP - Childhood Leukaemia Investigation Prague, Department of Paediatric Haematology and Oncology, Second Faculty of Medicine, Charles University and University Hospital Motol, Prague, Czech Republic.
245    10
$a How to make usage of the standardized EuroFlow 8-color protocols possible for instruments of different manufacturers / $c M. Nováková, H. Glier, N. Brdičková, M. Vlková, AH. Santos, M. Lima, M. Roussel, J. Flores-Montero, T. Szczepanski, S. Böttcher, VHJ. van der Velden, P. Fernandez, E. Mejstříková, L. Burgos, B. Paiva, JJM. van Dongen, A. Orfao, T. Kalina,
520    9_
$a A critical component of the EuroFlow standardization of leukemia/lymphoma immunophenotyping is instrument setup. Initially, the EuroFlow consortium developed a step-by-step standard operating protocol for instrument setup of ≥8-color flow cytometers that were available in 2006, when the EuroFlow activities started. Currently, there are 14 instruments from 9 manufacturers capable of 3-laser excitation and ≥8 color measurements. The specific adaptations required in the instrument set-up to enable them to acquire the standardized 8-color EuroFlow protocols are described here. Overall, all 14 instruments can be fitted with similar violet, blue and red lasers for simultaneous measurements of ≥8 fluorescent dyes. Since individual instruments differ both on their dynamic range (scale) and emission filters, it is not accurate to simply recalculate the target values to different scale, but adjustment of PMT voltages to a given emission filter and fluorochrome, is essential. For this purpose, EuroFlow has developed an approach using Type IIB (spectrally matching) particles to set-up standardized and fully comparable fluorescence measurements, in instruments from different manufacturers, as demonstrated here for the FACSCanto II, and Navios and MACSQuant flow cytometers. Data acquired after such adjustment on any of the tested cytometry platforms could be fully superimposed and therefore analyzed together. The proposed approach can be used to derive target values for any combination of spectrally distinct fluorochromes and any distinct emission filter of any new flow cytometry platform, which enables the measurement of the 8-color EuroFlow panels in a standardized way, by creating superimposable datafiles.
650    _2
$a průtoková cytometrie $x přístrojové vybavení $x normy $7 D005434
650    _2
$a hematologické nádory $x diagnóza $7 D019337
650    _2
$a lidé $7 D006801
650    _2
$a imunofenotypizace $x přístrojové vybavení $x normy $7 D016130
655    _2
$a časopisecké články $7 D016428
655    _2
$a práce podpořená grantem $7 D013485
700    1_
$a Glier, Hana $u Kantonsspital Aarau, Aarau, Switzerland.
700    1_
$a Brdičková, Naděžda $u CLIP - Childhood Leukaemia Investigation Prague, Department of Paediatric Haematology and Oncology, Second Faculty of Medicine, Charles University and University Hospital Motol, Prague, Czech Republic.
700    1_
$a Vlková, Marcela $u Department of Clinical Immunology and Allergology, St. Anne's University Hospital in Brno, Czech Republic.
700    1_
$a Santos, Ana Helena $u Laboratory of Flow Cytometry, Department of Hematology, Hospital de Santo António, Centro Hospitalar do Porto, Unidade Multidisciplinar de Investigação Biomédica (UMIB), Porto, Portugal.
700    1_
$a Lima, Margarida $u Laboratory of Flow Cytometry, Department of Hematology, Hospital de Santo António, Centro Hospitalar do Porto, Unidade Multidisciplinar de Investigação Biomédica (UMIB), Porto, Portugal.
700    1_
$a Roussel, Mikael $u Laboratoire d'Hématologie, Pôle Cellules et Tissus, CHU, INSERM UMR 1236, Rennes, France.
700    1_
$a Flores-Montero, Juan $u Cancer Research Centre (IBMCC, USAL-CSIC), Institute for Biomedical Research of Salamanca (IBSAL), Department of Medicine and Cytometry Service (NUCLEUS Research Support Platform), University of Salamanca (USAL), Salamanca and Centro de Investigación Biomédica en Red de Cáncer, Instituto Carlos III, Madrid, Spain.
700    1_
$a Szczepanski, Tomasz $u Department of Pediatric Hematology and Oncology, Zabrze Medical University of Silesia, Katowice, Poland.
700    1_
$a Böttcher, Sebastian $u University of Rostock, Division of Internal Medicine, Hematology laboratory, Medical Clinic III, Hematology, Oncology, and Palliative Medicine, Rostock, Germany.
700    1_
$a van der Velden, Vincent H J $u Department of Immunology, Laboratory for Medical Immunology, Erasmus MC, University Medical Center Rotterdam, Rotterdam, The Netherlands.
700    1_
$a Fernandez, Paula $u Kantonsspital Aarau, Aarau, Switzerland.
700    1_
$a Mejstříková, Ester $u CLIP - Childhood Leukaemia Investigation Prague, Department of Paediatric Haematology and Oncology, Second Faculty of Medicine, Charles University and University Hospital Motol, Prague, Czech Republic.
700    1_
$a Burgos, Leire $u Clínica Universidad de Navarra, Centro de Investigación Medica aplicada (CIMA), IDISNAm, Pamplona, Spain.
700    1_
$a Paiva, Bruno $u Clínica Universidad de Navarra, Centro de Investigación Medica aplicada (CIMA), IDISNAm, Pamplona, Spain.
700    1_
$a van Dongen, Jacques J M $u Department of Immunohematology and Blood Transfusion (IHB), Leiden University Medical Center (LUMC), Leiden, The Netherlands.
700    1_
$a Orfao, Alberto $u Cancer Research Centre (IBMCC, USAL-CSIC), Institute for Biomedical Research of Salamanca (IBSAL), Department of Medicine and Cytometry Service (NUCLEUS Research Support Platform), University of Salamanca (USAL), Salamanca and Centro de Investigación Biomédica en Red de Cáncer, Instituto Carlos III, Madrid, Spain.
700    1_
$a Kalina, Tomáš $u CLIP - Childhood Leukaemia Investigation Prague, Department of Paediatric Haematology and Oncology, Second Faculty of Medicine, Charles University and University Hospital Motol, Prague, Czech Republic. Electronic address: tomas.kalina@lfmotol.cuni.cz.
773    0_
$w MED00010028 $t Journal of immunological methods $x 1872-7905 $g Roč. 475, č. - (2019), s. 112388
856    41
$u https://pubmed.ncbi.nlm.nih.gov/29154914 $y Pubmed
910    __
$a ABA008 $b sig $c sign $y a $z 0
990    __
$a 20201125 $b ABA008
991    __
$a 20201214125955 $b ABA008
999    __
$a ok $b bmc $g 1595733 $s 1114090
BAS    __
$a 3
BAS    __
$a PreBMC
BMC    __
$a 2019 $b 475 $c - $d 112388 $e 20171120 $i 1872-7905 $m Journal of immunological methods $n J Immunol Methods $x MED00010028
LZP    __
$a Pubmed-20201125

Najít záznam

Citační ukazatele

Možnosti archivace